Search research articles
Contact Us
Filters
Showing results (341-350 of 475) with videos related to
Page
of 48
Sort By:
Journal of Affective Disorders
|
December 8, 2022
Chronobiological parameters as predictors of early treatment response in major depression
Nicóli B Xavier, Ana Carolina V O Abreu, Guilherme Rodriguez Amando, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
Kate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.
Scientific Reports
|
October 31, 2023
Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
Srinivasan Vairavan, Homa Rashidisabet, Qingqin S Li, et al.
Frontiers in Psychiatry
|
September 7, 2018
Prospective Assessment of Daily Patterns of Mood-Related Symptoms
Luísa K Pilz, Alicia Carissimi, Ana Paula Francisco, et al.
Bipolar Disorders
|
June 22, 2020
Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self-report approaches
Greg Murray, John Gottlieb, Maria Paz Hidalgo, et al.
Psychiatry Research
|
July 31, 2023
Response trajectories during escitalopram treatment of patients with major depressive disorder
John-Jose Nunez, Yang S Liu, Bo Cao, et al.
Journal of Psychopharmacology (Oxford, England)
|
May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report
Caroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Brain and Behavior
|
March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
Caroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
CNS Drugs
|
April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report
Emma Morton, Venkat Bhat, Peter Giacobbe, et al.
Psychological Medicine
|
December 29, 2025
Which aspects of anhedonia predict response to pharmacotherapy in major depressive disorder?
Rudolf Uher, Sakina J Rizvi, Lena C Quilty, et al.
Page
of 48
Search research articles
Search
Showing results (341-350 of 475) with videos related to
Sort By:
Page
of 48
Journal of Affective Disorders
|
December 8, 2022
Chronobiological parameters as predictors of early treatment response in major depression
Nicóli B Xavier, Ana Carolina V O Abreu, Guilherme Rodriguez Amando, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
Kate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.
Scientific Reports
|
October 31, 2023
Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
Srinivasan Vairavan, Homa Rashidisabet, Qingqin S Li, et al.
Frontiers in Psychiatry
|
September 7, 2018
Prospective Assessment of Daily Patterns of Mood-Related Symptoms
Luísa K Pilz, Alicia Carissimi, Ana Paula Francisco, et al.
Bipolar Disorders
|
June 22, 2020
Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self-report approaches
Greg Murray, John Gottlieb, Maria Paz Hidalgo, et al.
Psychiatry Research
|
July 31, 2023
Response trajectories during escitalopram treatment of patients with major depressive disorder
John-Jose Nunez, Yang S Liu, Bo Cao, et al.
Journal of Psychopharmacology (Oxford, England)
|
May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report
Caroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Brain and Behavior
|
March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
Caroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
CNS Drugs
|
April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report
Emma Morton, Venkat Bhat, Peter Giacobbe, et al.
Psychological Medicine
|
December 29, 2025
Which aspects of anhedonia predict response to pharmacotherapy in major depressive disorder?
Rudolf Uher, Sakina J Rizvi, Lena C Quilty, et al.
Page
of 48